Results 151 to 160 of about 10,513 (268)

Diet and Microbiota-Gut-Brain Axis: A Novel Nutritional Therapy. [PDF]

Nutrients
Markonda L, Henderson WA.
europepmc   +1 more source

Impact of a Structured Caesarean Reduction Strategy on Perinatal Outcomes: A Retrospective Ecological Time‐Trend Study

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Objective To evaluate the long‐term impact of a structured, multidisciplinary CS reduction strategy in a high‐complexity Italian hospital. Design Retrospective ecological time‐trend study. Setting Tertiary obstetric care Italian centre. Sample 28 577 deliveries, ≥ 22 weeks' gestation, from 2014 to 2024 were analysed.
Stefania Fieni, Giovanni Morganelli, Gabriella Maria Celora, Biancamaria Mastrandrea, Tullio Ghi   +4 more
wiley   +1 more source

Comparing mental health professionals' willingness to use digital therapeutics: a cross-national survey in South Korea and Germany. [PDF]

BMC Health Serv Res
Moon DU, Park S, Kim MJ, Gutwinski S, Bermpohl F, Bajbouj M, Jeon HJ, Lütt A.   +7 more
europepmc   +1 more source

Associations Between Dissociation and Childhood Trauma in Borderline Personality Disorder and Affective Disorders: A Network Analytic Approach

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Background Dissociation and childhood trauma are strongly associated with borderline personality disorder (BPD), yet it remains unclear whether this reflects disorder‐specific mechanisms or differences in symptom severity within a shared transdiagnostic structure. Objective Using network analysis, we examined whether the conditional dependency
Philipp Wülfing, Carsten Spitzer, Judy Leibowitz, Stephen Pilling, Peter Fonagy, P. Read Montague, Tobias Nolte   +6 more
wiley   +1 more source

Editorial: Re-imagining Neuro-inclusive Therapeutic Services

Murmurations
Monica Whyte, David Steare, Gail Simon
doaj   +1 more source

When to Consider Transcranial Magnetic Stimulation for Youth With Depression Given Promising Data on Effectiveness-Authors' Reply. [PDF]

JAACAP Open
Croarkin PE, Aaronson ST, Carpenter LL, Hutton TM, Pages KP, Sackeim HA.   +5 more
europepmc   +1 more source

Do We Need to Monitor B‐Vitamins and Homocysteine During Initiation of Foslevodopa/Foscarbidopa Therapy?

Movement Disorders, EarlyView.
Aida Shaghaghi‐Zadeh, Matthias Höllerhage, Florian Wegner, Lan Ye, Ishana Schneidereit, Tobias Hegelmaier, Rebecca Jacob, Christoph Schrader, Martin Klietz   +8 more
wiley   +1 more source

Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial

Addiction, EarlyView.
Abstract Background and Aims Psilocybin has emerged as a potential treatment for alcohol use disorder (AUD), but early efficacy data are inconsistent. Depression following alcohol detoxification significantly increases the risk of relapse. This pilot study aimed to evaluate the feasibility, acceptability, and preliminary efficacy of psilocybin‐assisted
Amandine Luquiens, Dahbia Belahda, Carine Graux, Noe Igounenc, Chris Serrand, Paul Rochefort, Thibault Mura, Felix Sergent   +7 more
wiley   +1 more source

Psilocybin in the Treatment of Cocaine Use Disorder: A Randomized Clinical Trial.

JAMA Netw Open
Hendricks PS, Lappan SN, Shelton RC, Lahti AC, Cropsey KL, Johnson MW, Bradley M, Simonsson O, Davis LL, Grossman DH, Ortiz CE.   +10 more
europepmc   +1 more source

Subjective cognition trajectories, Alzheimer biomarkers, and incident mild cognitive impairment. [PDF]

J Prev Alzheimers Dis
Kuhn E, Kleineidam L, Stark M, Peters O, Hellmann-Regen J, Preis L, Gref D, Priller J, Spruth EJ, Gemenetzi M, Schneider A, Fliessbach K, Wiltfang J, Bartels C, Hansen N, Rostamzadeh A, Düzel E, Glanz W, Incesoy E, Buerger K, Janowitz D, Stöcklein S, Perneczky R, Rauchmann BS, Teipel SJ, Kilimann I, Laske C, Sodenkamp S, Spottke A, Kronmüller M, Roeske S, Brosseron F, Ramirez A, Synofzik M, Schmid MC, Jessen F, Wagner M, Alzheimer’s Disease Neuroimaging Initiative, DELCODE study group.   +38 more
europepmc   +1 more source